Literature DB >> 18312765

Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort).

William B Kannel1, Ramachandran S Vasan, Michelle J Keyes, Lisa M Sullivan, Sander J Robins.   

Abstract

Increased triglycerides (TG) and decreased high-density lipoprotein (HDL) cholesterol are key metabolic abnormalities in patients with insulin resistance (IR) states, including diabetes mellitus. The TG/HDL cholesterol ratio was advocated as a simple clinical indicator of IR, but studies yielded inconsistent results. The total cholesterol/HDL cholesterol ratio was widely used to assess lipid atherogenesis, but its utility for assessing IR or its associated coronary heart disease (CHD) risk was unknown. TG/HDL cholesterol and total cholesterol/HDL cholesterol ratios were related to IR (top quartile of the homeostasis model assessment-IR) in 3,014 patients (mean age 54 years; 55% women). Logistic regression was used to construct receiver-operator characteristic curves for predicting IR, with lipid ratios as predictors. Multivariable Cox regression was used to evaluate whether adjusting for lipid ratios attenuated the association of IR with CHD. Cross sectionally, age- and gender-adjusted correlations of IR were 0.46 with TG/HDL cholesterol ratio and 0.38 with total/HDL cholesterol ratio. IR prevalence increased across tertiles of lipid ratios (p <0.0001). The area under the receiver-operator characteristic curves for predicting IR with TG/HDL cholesterol ratio was 0.745, slightly higher than that for total/HDL cholesterol ratio (0.707; p <0.001 for comparison). On follow-up (mean 6.4 years), 112 patients experienced initial CHD events. IR was associated with CHD risk (multivariable-adjusted hazards ratio 2.71, 95% confidence interval 1.79 to 4.11), which remained significant even after adjustment for lipid ratios. In conclusion, our observations suggested that the TG/HDL cholesterol ratio was an imperfect surrogate for IR and its associated CHD risk, and it was only slightly better than the total/HDL cholesterol ratio for this purpose.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312765      PMCID: PMC3753679          DOI: 10.1016/j.amjcard.2007.09.109

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.

Authors:  Milada Dobiásová
Journal:  Clin Chem       Date:  2004-07       Impact factor: 8.327

2.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

Authors:  G R Warnick; J Benderson; J J Albers
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

3.  Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.

Authors:  P Lempiäinen; L Mykkänen; K Pyörälä; M Laakso; J Kuusisto
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

4.  Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.

Authors:  J M Gaziano; C H Hennekens; C J O'Donnell; J L Breslow; J E Buring
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

5.  Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.

Authors:  J R McNamara; H Campos; J M Ordovas; J Peterson; P W Wilson; E J Schaefer
Journal:  Arteriosclerosis       Date:  1987 Sep-Oct

Review 6.  Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.

Authors:  S E Borggreve; R De Vries; R P F Dullaart
Journal:  Eur J Clin Invest       Date:  2003-12       Impact factor: 4.686

7.  Hyperinsulinemia as an independent risk factor for ischemic heart disease.

Authors:  J P Després; B Lamarche; P Mauriège; B Cantin; G R Dagenais; S Moorjani; P J Lupien
Journal:  N Engl J Med       Date:  1996-04-11       Impact factor: 91.245

8.  Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions.

Authors:  J R McNamara; E J Schaefer
Journal:  Clin Chim Acta       Date:  1987-06-30       Impact factor: 3.786

9.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

10.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

Authors:  I Zavaroni; E Bonora; M Pagliara; E Dall'Aglio; L Luchetti; G Buonanno; P A Bonati; M Bergonzani; L Gnudi; M Passeri
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

View more
  47 in total

1.  New evidence extending the benefit of treating LDL-C beyond the current guidelines.

Authors:  Michael Clearfield
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

2.  Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia.

Authors:  Sarinnapha Vasunilashorn; Eileen M Crimmins; Jung Ki Kim; Jeff Winking; Michael Gurven; Hillard Kaplan; Caleb E Finch
Journal:  Am J Hum Biol       Date:  2010 Nov-Dec       Impact factor: 1.937

3.  Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities.

Authors:  Rachel P Wildman; Aileen P McGinn; Juan Lin; Dan Wang; Paul Muntner; Hillel W Cohen; Kristi Reynolds; Vivian Fonseca; MaryFran R Sowers
Journal:  Obesity (Silver Spring)       Date:  2010-08-19       Impact factor: 5.002

Review 4.  Lipid parameters for measuring risk of cardiovascular disease.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt; John J P Kastelein
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

5.  When anger expression might be beneficial for African Americans: The moderating role of chronic discrimination.

Authors:  Jiyoung Park; Abdiel J Flores; Kirstin Aschbacher; Wendy Berry Mendes
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2018-05-24

6.  Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women.

Authors:  Ye-Li Wang; Woon-Puay Koh; Mohammad Talaei; Jian-Min Yuan; An Pan
Journal:  J Diabetes       Date:  2016-10-07       Impact factor: 4.006

7.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

8.  Triglyceride-to-HDL cholesterol ratio. Predictive value for CHD severity and new-onset heart failure.

Authors:  Z Yunke; L Guoping; C Zhenyue
Journal:  Herz       Date:  2013-04-17       Impact factor: 1.443

9.  Associations of Circulating Protein Levels With Lipid Fractions in the General Population.

Authors:  Sylwia M Figarska; Stefan Gustafsson; Johan Sundström; Johan Ärnlöv; Anders Mälarstig; Sölve Elmståhl; Tove Fall; Lars Lind; Erik Ingelsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

10.  Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: evidence from the Framingham Heart Study.

Authors:  Ping An; Mary Feitosa; Shamika Ketkar; Avril Adelman; Shiow Lin; Ingrid Borecki; Michael Province
Journal:  BMC Proc       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.